Drug Shortage Report for LEVOFLOXACIN IN 5% DEXTROSE INJECTION
Report ID | 193609 |
Drug Identification Number | 02314932 |
Brand name | LEVOFLOXACIN IN 5% DEXTROSE INJECTION |
Common or Proper name | LEVOFLOXACIN IN 5% DEXTROSE INJECTION |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | LEVOFLOXACIN |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 24 x 50mL bag |
ATC code | J01MA |
ATC description | QUINOLONE ANTIBACTERIALS |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | |
Actual start date | 2023-09-16 |
Estimated end date | |
Actual end date | 2025-02-06 |
Shortage status | Resolved |
Updated date | 2025-02-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2023-06-02 | French | Compare |
v1 | 2023-06-02 | English | Compare |